<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Efficacy of Nonhormonal Treatment for Patients With VMS Considered Unsuitable, Unwilling to Take Hormone Therapy

Default sub title

minute read

Written by Consultant360 on November 16, 2023

In this video, Nanette Santoro, MD, discusses the efficacy of nonhormonal treatment for patients with vasomotor symptoms (VMS), also called hot flashes or night sweats, in subgroups of patients considered unsuitable for or unwilling to take hormone therapy based on hormonal therapy history, the efficacy of the nonhormonal treatment for patients with VMS in menopause according to time of day, and pooled safety data over 52 weeks of the nonhormonal treatment for patients with VMS in menopause.

Topics: Press Coverage

Related Stories